Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FJW37
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,899
Award facts
- Contract value 100% obligated
- $20,898.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injector pharmaceutical product. This firm fixed-price delivery order, valued at $20,898.64, represents a non-competitive award with an ultimate completion date of September 11, 2025. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contracting presence as a critical medical supply vendor for the Defense Health Agency and related military healthcare systems. The company's role under the SPE2DX IDC includes supplying a broad portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to support military personnel and veteran healthcare needs worldwide. This specific delivery order for Repatha, a cardiovascular treatment medication, exemplifies the company's consistent performance in fulfilling federal pharmaceutical procurement requirements through its established relationship with the Defense Logistics Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FJW37?
SPE2DB25FJW37 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FJW37 worth?
The government has obligated $20,899 on SPE2DB25FJW37.
Is contract SPE2DB25FJW37 an order under another contract?
Yes. SPE2DB25FJW37 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJW37 competed?
The extent of competition for SPE2DB25FJW37 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award